1. Home
  2. PSNY vs TYRA Comparison

PSNY vs TYRA Comparison

Compare PSNY & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

HOLD

Current Price

$13.83

Market Cap

2.0B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$25.02

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNY
TYRA
Founded
2017
2018
Country
Sweden
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PSNY
TYRA
Price
$13.83
$25.02
Analyst Decision
Sell
Strong Buy
Analyst Count
2
11
Target Price
$15.00
$47.50
AVG Volume (30 Days)
124.7K
622.7K
Earning Date
04-17-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.06
N/A
Revenue Next Year
$47.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$9.96
52 Week High
$23.75
$40.65

Technical Indicators

Market Signals
Indicator
PSNY
TYRA
Relative Strength Index (RSI) 36.90 32.00
Support Level $12.36 $24.77
Resistance Level $15.01 $32.82
Average True Range (ATR) 0.78 1.70
MACD 0.13 -0.68
Stochastic Oscillator 41.59 2.12

Price Performance

Historical Comparison
PSNY
TYRA

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: